Vimta Labs

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE579C01029
NSEID: VIMTALABS
BSEID: 524394
View on NSE | View on BSE

INR

425.00

7.45 (1.78%)

BSENSE

Mar 25

BSE+NSE Vol: 1.45 lacs

{
  "main_header": {
    "sid": 179255,
    "name": "Vimta Labs",
    "stock_name": "Vimta Labs",
    "full_name": "Vimta Labs Ltd",
    "name_url": "stocks-analysis/vimta-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "425.00",
    "chg": 7.45,
    "chgp": "1.78%",
    "dir": 1,
    "prev_price": "417.55",
    "mcapval": "1,926.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524394,
    "symbol": "VIMTALABS",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "India SENSEX",
    "isin": "INE579C01029",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "1.45 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vimta-labs-179255-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Vimta Labs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vimta-labs-ltd-is-rated-sell-3917962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_mojoScore_3917962.png",
        "date": "2026-03-26 10:10:02",
        "description": "Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Vimta Labs Ltd Hits Intraday Low Amidst Price Pressure on 23 Mar 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-hits-intraday-low-amidst-price-pressure-on-23-mar-2026-3908232",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_priceRelatedfactors_3908232.png",
        "date": "2026-03-23 15:16:03",
        "description": "Vimta Labs Ltd experienced a significant intraday decline on 23 Mar 2026, touching a low of Rs 398.5, down 6.79% from previous levels. The stock underperformed its sector and broader market indices amid heightened volatility and persistent downward pressure."
      },
      {
        "title": "Vimta Labs Ltd Falls 4.36%: 2 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-falls-436-2-key-factors-driving-the-weekly-decline-3892406",
        "imagepath": "",
        "date": "2026-03-15 15:01:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Sharp gap down opening at Rs.400 amid market concerns</p>\n                    <p><strong>5 Mar:</strong> Valuation metrics shift from expensive to fair, signalling changing sentiment</p>\n                    <p><strong>6 Mar:</strong> Week closes at Rs.432.30, down 4.36%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.452.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.432.30</div><div class=\"stat-change negative\">-4.36%</div></div>\n                    <div class=..."
      },
      {
        "title": "Vimta Labs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vimta-labs-ltd-is-rated-sell-3892227",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_mojoScore_3892227.png",
        "date": "2026-03-15 10:10:02",
        "description": "Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Vimta Labs Ltd Valuation Shifts Signal Price Attractiveness Decline Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-valuation-shifts-signal-price-attractiveness-decline-amid-sector-dynamics-3884221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_valuationdot_3884221.png",
        "date": "2026-03-11 08:00:13",
        "description": "Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has seen its valuation metrics shift notably, moving from fair to expensive territory. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, prompting a downgrade in its investment grade. This article analyses the valuation changes, compares them with sector peers, and examines the implications for investors amid the company’s mixed market performance."
      },
      {
        "title": "Vimta Labs Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-valuation-shifts-signal-changing-market-sentiment-3872422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_valuationdot_3872422.png",
        "date": "2026-03-05 08:00:10",
        "description": "Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and relative peer comparisons, prompting a downgrade in its overall rating to Sell from Hold as of 16 January 2026."
      },
      {
        "title": "Vimta Labs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vimta-labs-ltd-is-rated-sell-3869051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_mojoScore_3869051.png",
        "date": "2026-03-04 10:10:02",
        "description": "Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Vimta Labs Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vimta-labs-ltd-opens-with-significant-gap-down-amid-market-concerns-3865166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VimtaLabsLtd_gapdown_3865166.png",
        "date": "2026-03-02 13:31:40",
        "description": "Vimta Labs Ltd, a key player in the Healthcare Services sector, opened the trading session on 2 Mar 2026 with a pronounced gap down, declining 11.5% from its previous close. This weak start reflects ongoing market apprehensions, with the stock underperforming its sector and broader indices amid sustained selling pressure."
      },
      {
        "title": "Vimta Labs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vimta-labs-ltd-is-rated-sell-3849397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VimtaLabsLtd_mojoScore_3849397.png",
        "date": "2026-02-21 10:10:05",
        "description": "Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 5786,
    "sid": "179255",
    "stock_news_url": "https://www.marketsmojo.com/news/vimta-labs-179255"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "24-Mar-2026",
      "details": "Intimation of Schedule of Analyst/ Institutional Investors Meet to be held on 27th March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "09-Mar-2026",
      "details": "Allotment of ESOPs under Vimta Labs Employee Stock Option Plan 2021.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Feb-2026",
      "details": "Intimation of Schedule of Analyst/Institutional Investor Meet to be held on 27th February2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has declared <strong>100%</strong> dividend, ex-date: 30 May 25",
          "dt": "2025-05-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 24 Feb 06",
          "dt": "2006-02-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Vimta Labs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vimta Labs Ltd is Rated Sell

2026-03-26 10:10:02

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Vimta Labs Ltd Hits Intraday Low Amidst Price Pressure on 23 Mar 2026

2026-03-23 15:16:03

Vimta Labs Ltd experienced a significant intraday decline on 23 Mar 2026, touching a low of Rs 398.5, down 6.79% from previous levels. The stock underperformed its sector and broader market indices amid heightened volatility and persistent downward pressure.

Read full news article

Vimta Labs Ltd Falls 4.36%: 2 Key Factors Driving the Weekly Decline

2026-03-15 15:01:12

Key Events This Week

2 Mar: Sharp gap down opening at Rs.400 amid market concerns

5 Mar: Valuation metrics shift from expensive to fair, signalling changing sentiment

6 Mar: Week closes at Rs.432.30, down 4.36%

Read full news article

Vimta Labs Ltd is Rated Sell

2026-03-15 10:10:02

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Vimta Labs Ltd Valuation Shifts Signal Price Attractiveness Decline Amid Sector Dynamics

2026-03-11 08:00:13

Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has seen its valuation metrics shift notably, moving from fair to expensive territory. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceed historical and peer averages, prompting a downgrade in its investment grade. This article analyses the valuation changes, compares them with sector peers, and examines the implications for investors amid the company’s mixed market performance.

Read full news article

Vimta Labs Ltd Valuation Shifts Signal Changing Market Sentiment

2026-03-05 08:00:10

Vimta Labs Ltd, a prominent player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and relative peer comparisons, prompting a downgrade in its overall rating to Sell from Hold as of 16 January 2026.

Read full news article

Vimta Labs Ltd is Rated Sell

2026-03-04 10:10:02

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Vimta Labs Ltd Opens with Significant Gap Down Amid Market Concerns

2026-03-02 13:31:40

Vimta Labs Ltd, a key player in the Healthcare Services sector, opened the trading session on 2 Mar 2026 with a pronounced gap down, declining 11.5% from its previous close. This weak start reflects ongoing market apprehensions, with the stock underperforming its sector and broader indices amid sustained selling pressure.

Read full news article

Vimta Labs Ltd is Rated Sell

2026-02-21 10:10:05

Vimta Labs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.